On July 26, 2017, FUJIFILM Corporation (Headquarters: Minato-ku, Tokyo, President: Kenji Sukeno) and Bonac have agreed to form a capital alliance. In conjunction with this capital alliance, a joint research agreement will be concluded with the aim of creating innovative nucleic acid drugs.

 

Bonac will continue to promote research and development so that our nucleic acid chemistry technology will become a bridge to drug discovery.

 

Contact:

Corporate Affairs

press@bonac.co.jp

Fujifilm's capital participation in Bonac (Japanese version only)